UK-based sweets to soft drinks group, Cadbury Schweppes, is preparing a $2bn bid for Adams, the US confectionery subsidiary of the Pfizer pharmaceuticals group. The company is keen to buy Adams because of its strong position in the US chewing gum market with brands such as Trident, Dentyne, Bubbaloo and Bubbilicious. Adams also produces the Clorets and Halls Mentho-Lyptus brands.